Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
alzheimer's disease
biogen
3
×
biotech
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
deals
detroit blog main
detroit top stories
glaxosmithkline
3
×
indiana blog main
indiana top stories
life sciences
merck
national
national blog main
national top stories
new york blog main
new york top stories
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
3
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
aduro biotech
amgen
bristol-myers squibb
cancer
clinical trials
What
bio
roundup
crispr
drug
acquisitions
albert
alliance
approval
biggest
biogen’s
biopharmaceutical
bourla
bristol
buy
calls
ceo
changing
color
companies
company
convo
days
earlier
failures
future
growing
hours
imports
kudos
leaves
littered
maker
maps
measured
myers’s
nash
new
news
notifying
october
Language
unknown
unset
Current search:
glaxosmithkline
×
startups
×
biotech
×
photo
×
" new york top stories "
×
biogen
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More